Topline Ozempic and Mounjaro manufacturers are being sued over claims that the drugs cause gastroparesis, a severe stomach disorder, but some experts believe this assertion is inaccurate because the drugs only cause a temporary delay in stomach emptying
If youre researching GLP-1 weight loss programs, youll find numerous telehealth options, each with different pricing structures, medication offerings, and program features
doi :10.1515/BC.2009.033 Allen J, Bradley RD
Clinically, a recent trial consisting of prediabetic/overweight smokers given exenatide, a GLP-1 RA, in conjunction with nicotine patch improved abstinence rates along with lower drug cravings and withdrawals
No pattern of severe complications emerged that would suggest unique safety concerns beyond those established for the GLP-1 agonist class